AU2513592A - Hepatitis c assay utilizing recombinant antigens to ns1 - Google Patents
Hepatitis c assay utilizing recombinant antigens to ns1Info
- Publication number
- AU2513592A AU2513592A AU25135/92A AU2513592A AU2513592A AU 2513592 A AU2513592 A AU 2513592A AU 25135/92 A AU25135/92 A AU 25135/92A AU 2513592 A AU2513592 A AU 2513592A AU 2513592 A AU2513592 A AU 2513592A
- Authority
- AU
- Australia
- Prior art keywords
- ala
- val
- leu
- gly
- arg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74856191A | 1991-08-21 | 1991-08-21 | |
| US748561 | 1991-08-21 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2513592A true AU2513592A (en) | 1993-03-16 |
Family
ID=25009968
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU25135/92A Abandoned AU2513592A (en) | 1991-08-21 | 1992-08-21 | Hepatitis c assay utilizing recombinant antigens to ns1 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0600009A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JPH06510191A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2513592A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2115926A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW213924B (cg-RX-API-DMAC7.html) |
| WO (1) | WO1993004088A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6762024B2 (en) * | 1993-04-27 | 2004-07-13 | Innogenetics, S.A. | Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents |
| ES2197170T3 (es) * | 1993-11-04 | 2004-01-01 | Innogenetics N.V. | Epitopos de celulas t humanas inmunologicamente dominantes del virus de la hepatitis c. |
| US5610009A (en) * | 1994-01-28 | 1997-03-11 | Abbott Laboratories | Mammalian expression systems for hepatitis C virus envelope genes |
| EP1845108A3 (en) * | 1994-07-29 | 2007-10-24 | Innogenetics N.V. | Monoclonal antibodies to purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| US6329157B1 (en) | 1998-05-28 | 2001-12-11 | Abbott Laboratories | Antigen cocktails and uses thereof |
| US7196183B2 (en) | 2001-08-31 | 2007-03-27 | Innogenetics N.V. | Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent |
| US8124747B2 (en) | 2003-08-29 | 2012-02-28 | Innogenetics | HCV clade and prototype sequences thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989004669A1 (en) * | 1987-11-18 | 1989-06-01 | Chiron Corporation | Nanbv diagnostics and vaccines |
| US5124255A (en) * | 1988-03-11 | 1992-06-23 | Abbott Laboratories | CKS method of protein synthesis |
| HUT54896A (en) * | 1989-03-17 | 1991-04-29 | Chiron Corp | Process for producing aquous diagnosticum and vaccine of nanbv |
| US5106726A (en) * | 1990-02-16 | 1992-04-21 | United Biomedical, Inc. | Synthetic peptides specific for the detection of antibodies to HCV |
-
1992
- 1992-08-21 WO PCT/US1992/007188 patent/WO1993004088A1/en not_active Ceased
- 1992-08-21 JP JP5504658A patent/JPH06510191A/ja active Pending
- 1992-08-21 CA CA 2115926 patent/CA2115926A1/en not_active Abandoned
- 1992-08-21 EP EP92918853A patent/EP0600009A4/en not_active Withdrawn
- 1992-08-21 AU AU25135/92A patent/AU2513592A/en not_active Abandoned
- 1992-09-03 TW TW81106995A patent/TW213924B/zh active
Also Published As
| Publication number | Publication date |
|---|---|
| EP0600009A4 (en) | 1995-03-01 |
| WO1993004088A1 (en) | 1993-03-04 |
| CA2115926A1 (en) | 1993-03-04 |
| JPH06510191A (ja) | 1994-11-17 |
| EP0600009A1 (en) | 1994-06-08 |
| TW213924B (cg-RX-API-DMAC7.html) | 1993-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5871903A (en) | HCV isolates | |
| Falgout et al. | Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity | |
| US6593083B1 (en) | Hepatitis C assay utilizing recombinant antigens | |
| ES2141081T5 (es) | Nuevo aislado de hcv j-1. | |
| EP0472207B1 (en) | Hepatitis C assay utilizing recombinant antigens | |
| CN100365017C (zh) | 肺炎衣原体抗原多肽 | |
| CA2005950C (en) | Non-a, non-b hepatitis virus genome rna, cdna and virus antigen protein | |
| Pilot‐Matias et al. | Identification of antigenic regions in the GB hepatitis viruses GBV‐A, GBV‐B, and GBV‐C | |
| AU716379B2 (en) | Methodology to produce, purify and assay polypeptides with the proteolytic activity of the HCV NS3 protease | |
| EP1227323B1 (en) | Non-A, non-B hepatitis virus antigen, and diagnostic methods | |
| Pereboeva et al. | Hepatitis C epitopes from phage‐displayed cDNA libraries and improved diagnosis with a chimeric antigen | |
| WO1993004088A1 (en) | Hepatitis c assay utilizing recombinant antigens to ns1 | |
| CN101784561A (zh) | 用于诊断或筛选节肢介体病毒感染的方法、在所述方法和它们的应用中使用的试剂 | |
| Shoji et al. | Proteolytic activity of NS3 serine proteinase of hepatitis C virus efficiently expressed in Escherichia coli | |
| CA2070952A1 (en) | Gene of hepatitis c virus or fragment thereof, polypeptide encoded by the same | |
| US5800982A (en) | Antigenic peptides for growing hepatitis C virus, kit comprising the same and methods for its grouping using the same | |
| EP0600000A1 (en) | Hepatitis c assay utilizing recombinant antigens from ns5 region | |
| CA2116026C (en) | Hepatitis c assay utilizing recombinant antigens to c-100 region | |
| Gwack et al. | NTPase activity of hepatitis C virus NS3 protein expressed in insect cells | |
| Khanna et al. | Hepatitis C virus core protein: synthesis, affinity purification and immunoreactivity with infected human sera | |
| JPH06507552A (ja) | 肝炎疾患の診断において有用なdna配列及びコードされたポリペプチド | |
| Seki et al. | Effective production of the hepatitis C virus core antigen having high purity in Escherichia coli | |
| US7491808B2 (en) | HCV non-structural protein mutants and uses thereof | |
| US6030771A (en) | Mosaic protein and restriction endonuclease assisted ligation method for making the same | |
| JP3669717B2 (ja) | C型肝炎ウイルスのグルーピングのための抗原性ペプチド、それを含有するキットおよびそれを使用するグルーピング方法 |